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Edited by Jesus AvilaAbstract Nervous system polycomb 1 (NSPc1) shares high
homology with vertebrate PcG proteins Mel-18 and Bmi-1.
The mRNA of NSPc1 is highly expressed in the developmental
nervous system [Mech. Dev. 102 (2001) 219–222]. However,
the functional characterization of NSPc1 protein is not clear.
In the present study, using Western blotting technique, we aimed
to describe the distributions of NSPc1 protein in rat tissues and
cell lines. The subcellular localization of NSPc1 was examined in
HeLa and SH-SY5Ycell lines, and its transcriptional repression
activity was examined in COS-7 cell line. We found that the
NSPc1 protein was localized mainly in the nucleus. NSPc1
remarkably repressed the transcription. Most interestingly, both
the C-terminal of NSPc1 and two phosphorylation sites in the C-
terminal, especially the PKC phosphorylation site at S183, were
important in mediating transcription repression. Taken together,
results from our study suggest that NSPc1, as a typical PcG
family member, has powerful transcriptional repression ability,
which may be related to the PKC signaling pathway.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The RING ﬁnger proteins play an important role in a vari-
ety of fundamental cellular processes [2–4]. Some members of
the Polycomb group (PcG) bear RING ﬁnger domain and are
deﬁned as a subclass of RING ﬁnger proteins, such as Dro-
sophila posterior sex combs and suppressor 2 of zeste [5,6],
whose RING ﬁngers are conserved in vertebrate PcG proteins
Mel-18 [7] and Bmi-1 [8]. PcGs have been identiﬁed as tran-Abbreviations: NSPc1, nervous system polycomb 1; PcG, polycomb
group; COS-7, African green monkey cell line producing T antigen of
SV40; HeLa, human cervical carcinoma cell line; SH-SY5Y, human
neuroblastoma cell line; PCR, polymerase chain reaction; PKC, pro-
tein kinase C; PRE, polycomb-responsive element; NLS, nuclear loc-
alization signal
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through polycomb-responsive element (PRE) [9,10]. Recently,
it was found that both nervous system polycomb 1 (NSPc1) [1]
and MBLR [11] belong to this subclass.
Human NSPc1 gene encodes a protein with an N-terminal
RING ﬁnger domain and shares high homology with Mel-18
and Bmi-1. The mRNA of NSPc1 is highly expressed in the
mouse developmental nervous system. At 11.5 dpc, transcripts
are present in a subset of neural crest cell derivatives of the
peripheral nervous system and in the neural tube. In adult tis-
sue, NSPc1 expression is ubiquitous. Up to now, little is
known about the NSPc1 protein and the activities of NSPc1
in mammalian cells. Here, we characterized the distributions
and transcriptional repression activity of NSPc1 protein, and
found that its repression activity was related to its PKC phos-
phorylation site at S183.2. Materials and methods
2.1. Polyclonal antibody preparation
To prepare polyclonal anti-NSPc1 antibody, full-length cDNA clone
of human NSPc1 was subcloned into pET system vectors (Invitrogen,
USA), recombinant protein was overexpressed as His 6-tag fusion pro-
tein in Escherichia coli (BL21, DE3) and puriﬁed with Ni–NTA beads
(QIAGEN, USA), rabbits were immunized four times, then rabbit
anti-serum against recombinant human NSPc1 was collected and puri-
ﬁed through (NH4)2SO4 salting-out procedure [12].
2.2. Western blot analysis
Tissues of adult rat were homogenized in the whole cell extract buf-
fer (25 mM HEPES–KOH, pH 7.9, 1 mM EDTA, 0.5 mM DTT, and
0.2 mM PMSF) at 4 C for 15 min, then the suspension was transferred
into a cold Eppendorf tube and centrifuged at 1500 · g for 10 min at 4
C. To prepare the whole cell extracts, cultured cells in 100 mm dishes
were washed twice with PBS and then gently scraped into the whole
cell extract buﬀer at 4 C for 15 min. After swelling, the lysates were
homogenized. The cell suspension was transferred into a cold tube
and centrifuged at 1500 · g for 10 min at 4 C. The total amount of
protein in cell extracts was determined by Bradford colorimetric assay
[13].
Equal amounts of protein (20–40 lg) were mixed with 6· Laemmli
lysis buﬀer, boiled for 5 min, separated on a 10% denaturing SDS–
PAGE gel, and transferred to a nitrocellulose ﬁlter using a semi-dry
transfer apparatus (Bio-Rad, USA). Non-speciﬁc antibody–antigen
binding on the nitrocellulose ﬁlter was blocked by incubating in
5.0% milk/TBS for 1 h at room temperature. This was followed by
hybridizing the membranes overnight with rabbit polyclonal antibod-
ies against NSPc1 at a dilution of 1:1000 in 5% milk/TBS at 4 C.blished by Elsevier B.V. All rights reserved.
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incubated with the appropriate secondary antibody (Santa Cruz Bio-
technology, Santa Cruz, CA) conjugated with AP (1:1000 dilution)
at room temperature for 1 h. The BCIP/NBT kit (Sigma, USA) was
used as chromagen.
2.3. Cell culture and transfection
HeLa cells were maintained in Dulbeccos modiﬁed Eagles medium
(DMEM) and SH-SY5Y were maintained in RMPI 1640 with 10%
heat-inactivated FBS, 50 U/ml penicillin, and 50 lg/ml streptomycin
under a humidiﬁed atmosphere of 5% CO2 and 95% air at 37 C.
Transfection was performed using Lipofectamine (Gibco BRL),
according to the manufacturers instructions.
2.4. Subcellular localizations of extraneous GFP-taged-NSPc1 and
endogenous NSPc1 proteins
For analysis of subcellular localizations of NSPc1-GFP protein in
mammalian cells, exponentially growing HeLa cells were plated at
the density of 2.0 · 105/well on a six-well plate and transfected with
pEGFP-NSPc1 plasmid (3 lg/well). After 30 h, cells were washed twice
with PBS and ﬁxed in freshly prepared 3.7% paraformaldehyde for
15 min at room temperature. Then, the cells were washed twice
with PBS and incubated with DAPI for 15 min at 37 C for nuclear
counterstaining.
For the immunoﬂuorescence experiments to detect the localizations
of endogenous NSPc1 protein in mammalian cells, HeLa and SH-
SY5Y cells growing on glass coverslips were washed twice with PBS
and ﬁxed in freshly prepared 3.7% paraformaldehyde for 15 min at
room temperature. The cells were washed twice for 3 min with PBS
and permeabilized with PBS containing 0.5% Triton X-100 for 5 min
at room temperature. After washing, the cells were blocked with
PBS containing 10% FBS and 0.02% Triton X-100 for 1 h, and then
incubated with 1:100 diluted anti-NSPc1 antibody for 30 min in PBS
containing 0.02% TritonX-100. The cells were reacted with 1:100 di-
luted goat anti-rabbit IgG coupled with FITC or TRITC (Santa Cruz
Biotechnologies, Santa Cruz, CA) in blocking solution for 1 h at room
temperature. Cells were incubated with DAPI for 15 min at 37 C for
nuclear counterstaining after staining with the secondary antibody.
After being washed 3 times in PBS, the transfected or stained cells
were then carefully mounted onto the slides in a suitable mounting
medium containing anti-fade (1 mg/ml paraphenyl diamine in 90%
glycerol prepared in 0.01 M PBS, pH 7.2). Coverslips were sealed to
the slides using nail enamel and were viewed with the help of a normal
ﬂuorescence microscope (Nikon TE200 ﬂuorescent inverted micro-
scope equipped with a digital camera) or a confocal laser microscope
(Carl Zeiss, Laser Scanning Microscope, LSM510).
The method for subcellular fractionation was described by Dignam
et al. [14]. Western blot analysis was done as mentioned above. The
mouse anti-ß-tubulin monoclonal antibody (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) was used to conﬁrm correct fractionation.Fig. 1. Western blot analysis of NSPc1 protein. (A) Western blot
analysis of NSPc1 protein in various rat adult tissues. Each lane
contains 40 lg of total protein. (B) NSPc1 expressed in human tumor
cell lines. Each lane contained 20 lg of whole cell protein. The
endogenous NSPc1 protein with molecular weight of about 62 kDa
was indicated by an arrowhead. (C) Post translation modiﬁcations of
NSPc1. The box represents full length human NSPc1 protein. The
scale inside the box and the numbers underside the box indicate the
relative position of various modiﬁcations.2.5. Site-speciﬁc mutagenesis
To mutate the tyrosine kinase phosphorylation site at Y97 and the
protein kinase C phosphorylation site at S183 of NSPc1, we applied
the speciﬁc site mutation PCR method as described by Higuchi [15].
The primers were designed as follows: internal primers for Y97F:
Nspc1-tyr-MF: 5-CAGGACATCGTGTTTAAGCTGGTGCCT-3;
Nspc1-tyr-MR: 5-AGGCACCAGCTTAAACACGATGTCCTG-3;
Internal primers for S183F: Nspc1-pkc-MF: 5-AGTATGTCCGA-
TGTTTTGTTAGAGCTGAGGT-3; Nspc1-pkc-MR: 5-ACCTCAG-
CTCTAACAAAACATCGGACATACT-3. The outside primers:
Nspc1-pM1: 5-CGGGATCCCGATGAGGCTTCGGAACCAG-3;
Nspc1-pM2: 5-CCAAGCTTGGCCCCTACCTCCTCTTCTC-3. The
mutated sites were indicated by the black boxes. Both mutations were
conﬁrmed by sequencing.
2.6. Repression activity assays
Full-length Bmi-1, NSPc1 and its derivates were subcloned into the
pM vector (fusion vector of GAL4-DBD, Clontech). Full-length Mel-
18 in pM vector was a gift from Dr. Haruhiko Koseki in Chiba Uni-
versity. The luciferase reporter construct, pFR-Luc, contains ﬁve
GAL4 binding elements upstream of the SV40 promoter (Promega,USA). Expression values were standardized against Renillareniformis
luciferase expression from pRL-TK reference plasmid (Promega,
USA) [11].
Exponentially growing COS-7 cells were seeded onto 24-well plates
at a density of 2 · 104 cells/well one day prior to transfection. COS-7
cells were transfected with pM-empty, pM-Bmi-1, pM-Mel-18 or
pM-NSPc1 and its derivative constructs (200 ng/well), together with re-
port plasmid pFR-Luc (300 ng/well), and pRL-TK (100 ng/well) as an
internal control. Each transfection reaction was performed in triplicate
wells. After 24 h, the medium was replaced, and cells were harvested
and assayed for luciferase activity 36–48 h after transfection. Lucifer-
ase activity was measured by the Dual-luciferase reporter assay system
(Promega, USA).3. Results
3.1. Western blotting analysis of NSPc1 protein
Rabbit polyclonal anti-NSPc1 antibody was used. After
evaluating the speciﬁcity of the antibody (see supplemental
materials online), Western blot was employed to analyze ex-
tracts from adult rat tissues (brain, cerebellum, testis, heart, li-
ver, spleen, and colon) (Fig. 1A), from tumor cell lines (Fig.
1B) such as HeLa cells and U2OS osteosarcoma cells, which
are known to express high levels of PcG proteins, and nervous
system cell lines such as SH-SY5Y (neuroblastoma), NG108-
15 (mouse neuroblastoma; rat glioma, hybrid), and U251 (glio-
blastoma; astrocytoma). NSPc1 protein is highly expressed in
adult rats brain, cerebellum, heart and testis, which is similar
to the mRNA expression pattern of NSPc1 in mouse [1]. And
NSPc1 protein is relative highly expressed in SH-SY5Y,
NG108-15 and U251, which are all derived from nervous sys-
tem. Bands with molecular weight of approximately 62 kDa
Fig. 2. Subcellular localization of transfected pEGFP-NSPc1 and endogenous NSPc1 in HeLa and SH-SY5Y Cells. HeLa cells were transiently
transfected with pEGFP-NSPc1 expression vectors. Intracellular localization of NSPc1 was examined by normal (A) or confocal laser
(B) ﬂuorescence microscopy. (C) HeLa and SH-SY5Y cells were immunostained with rabbit anti-hNSPC1 and the immunostaining signals were
visualized with FITC/TRITC-conjugated anti-rabbit IgG antibodies. DAPI was used for nuclear counter staining. (D) The Western blot analysis of
the subcellular fractionation of HeLa and SH-SY5Y cells. Each lane contained 20 lg of whole cell protein. The mouse anti-ß-tubulin monoclonal
antibody was used to conﬁrm correct fractionation.
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were larger than theoretical molecular weight, they were in
accordance with the exhibition of PcGs [11,12], which are usu-
ally heavily post-translation modiﬁed. (Fig. 1C).
3.2. Subcellular localization of transfected pEGFP-NSPc1 and
endogenous NSPc1 protein
The pEGFP-NSPc1 was transfected into HeLa cells in order
to detect the subcellular localizations of NSPc1 protein. As
shown by normal ﬂuorescence microscopy, GFP-tagged-
NSPc1 protein distributed mainly in nucleus when overexpres-
sed in the cells (Fig. 2A), which was further conﬁrmed by
combined image using confocal laser ﬂuorescence microscopy
(Fig. 2B). The NSPc1 protein also exists, at least partially, in
the cytoplasm as demonstrated by the presence of ﬂuorescence
signals in the perinuclear cytoplasm. By using immunoﬂuores-
cence, similar distribution pattern was observed in cultured cell
lines (e.g., HeLa cells and SH-SY5Y cells). The endogenous
NSPc1 protein was mainly seen in the nucleus of cells and less
in the cytoplasm (Fig. 2C). The staining of these cell lines using
pre-immune serum did not show any speciﬁc staining (data not
shown).
To conﬁrm this result by biochemical analysis, we used the
nuclear-cytoplasm fractionation method [14]. Cells were lysedand separated into the nuclear and the cytoplasmic fractions.
Each fraction was immunoblotted with rabbit anti-NSPc1
polyclonal antibody and mouse anti-ß-tubulin monoclonal
antibody to conﬁrm correct fractionation. The NSPc1 proteins
were detected mostly in nuclear fraction and low in cytoplas-
mic fraction (Fig. 2D). These data prove that the endogenous
NSPc1 protein localized mainly to the nucleus.
3.3. NSPc1 is a transcriptional repressor
Mel-18 and Bmi-1, like all other PcG proteins, act as tran-
scriptional repressors when tethered to the episomal reporter
plasmid [16,17]. The structural similarity of NSPc1 to Mel-18
and Bmi-1 prompted us to examine its transcriptional activity
in transiently transfected mammalian cells. The GAL4-DBD-
NSPc1-fusion protein showed a higher repressor activity than
that of both the GAL4-DBD-Mel-18 and GAL4-DBD-Bmi-
1-fusion proteins in COS-7 cells (Fig. 3A). Co-transfecting
various amounts of the pM-NSPc1 plasmid with the reporter
plasmid into COS-7 cells resulted in up to 85% repression of
luciferase activity in a dose-dependent manner (Fig. 3B). Since
the sequence of NSPc1 shares high homology with Mel-18 and
Bmi-1, in the following studies, we tried to test whether NSPc1
was competitive against Mel-18 or Bmi-1 in transcriptional
repression activity. As shown in Fig. 3C, when co-transfecting
Fig. 3. Transcriptional repression activity of NSPc1. (A) NSPc1 bears
a stronger transcriptional repression activity than Mel-18 and Bmi-1.
COS-7 cells were serially co-transfected with equal amounts of the pM-
empty, pM-NSPc1, pM-Mel-18 or pM-Bmi-1 plasmid (200 ng/well)
together with the reporter plasmid pFR-LUC (200 ng/well) and the
internal control plasmid pRL-TK (100 ng/well). (B) Dosage-dependent
transcriptional repression by NSPc1. COS-7 cells were co-transfected
with increasing amounts of pM-NSPc1 plasmid (100–800 ng/well)
together with the reporter plasmids pFR-LUC (200 ng/well) and pRL-
TK (100 ng/well). (C) Overexpressing V5-taged-NSPc1 aﬀects the
transcriptional repression activity of pM-NSPc1 but not of pM-Mel-18
and pM-Bmi-1 in vivo. COS-7 cells were co-transfected with increasing
amounts of the pcDNA3.1-V5 + NSPc1 plasmid (50–400 ng/well)
together with pM-NSPc1, pM-Bmi-1 and pM-Mel-18 plasmids (200
ng/well) and the reporter plasmids: pFR-LUC (200 ng/well) and pRL-
TK (100 ng/well). Results were obtained from three diﬀerent transfec-
tion experiments after normalization for the internal control of TK
activity and experimental variations are indicated as shown.
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NSPc1 lost the repression activity in a dose-dependent manner
while pM-Mel-18 and pM-Bmi-1 kept their repression activity
unchanged.
3.4. The transcriptional repression ability of NSPc1 is related to
PKC phosphorylation site at S183
To identify the essential regions and sites for repression, bio-
informatics analysis of NSPc1 protein was performed (Fig. 4A)
followed by a series of truncated mutants constructing and
repression activities measurement (Fig. 4B). Luciferase expres-
sion values were obtained in the presence of pM-empty vector
as a control of repression. It is shown that N3 fragment (1–
103 aa), which contains the Ring ﬁnger domain, lost the repres-
sion activity completely, while the C1 fragment (74–247 aa) had
almost the same repression activity as the full length NSPc1.
The C5 fragment (104–247 aa) also lost the repression activity.
By comparing C5 with N3 and C1, we could predict that the re-gion from 74 to 104 aa, which contains a tyrosine kinase phos-
phorylation site, is necessary but not suﬃcient for repression.
Subsequently, we found that the N1 fragment (1–234 aa) exhib-
ited maximal repression activity, while the N2 fragment (1–180
aa) lost its repression activity. It indicated that the 235–247
amino acids in the C-terminus of NSPc1 were not required
for repression but the region of 180–234 aa was important. Be-
cause there are two PKC phosphorylation sites (S183 and
T220) within this region (Fig. 4A), to ﬁnd out which site was
more important for repression, we compared the repression
activity of C2 (74–234 aa) and C3 (74–196 aa) fragments as well
as of C4 (74–180 aa) and C3 (74–196 aa) fragments, and found
that the region of 180–196 aa had more eﬀect on the repression.
The tyrosine kinase phosphorylation site within 90–97 aa of
NSPc1 (Y97) and the PKC phosphorylation site within 180–
196 aa of NSPc1 (S183) were chosen for in vivo mutagenesis
analysis (Fig. 5A). The site speciﬁc PCR mutation technique
[15] was used to create the mutations of Y97F and S183F of
NSPc1, which were named mTYR and mPKC and fused to
GAL4-DBD, respectively. Transcription repression assay
showed that mTYR and mPKC remarkably aﬀected the
repression activity of NSPc1 (Fig. 5B), especially the mPKC al-
most completely abolished the repression activity. It suggests
that transcriptional repression activity of NSPc1 has a poten-
tial relationship with the PKC signaling pathway.4. Discussion
In the present study, we revealed that NSPc1 protein is
abundant in adult rats nervous tissue, heart, testis and several
nervous derived system cell lines. It is complementary to the
expression of NSPc1 mRNA [1]. Since in man, NSPc1 maps
within a 10.3 cM region associated with susceptibility to Par-
kinsons disease (PARK3) [18]. These suggest that NSPc1 pro-
tein may be important in physiological and pathological
processes of the mature nervous system.
Using bioinformatics analysis, we conferred NSPc1 as a nu-
clear protein and proved that NSPc1 protein mainly localized
in the nucleus of HeLa and SH-SY5Ycell lines.
Further studies demonstrated that NSPc1 acts as a transcrip-
tional repressor in transiently transfected COS-7 cells similar to
other PcG proteins. The transcriptional repression activity of
NSPc1 is more powerful than Mel-18 and Bmi-1. The compet-
itive experiment suggests that, unlike Mel-18 or Bmi-1 existing
in the same PcG complex [19,20], the transcriptional repression
process of NSPc1 may involve diﬀerent factors.
Cohen et al. [17] have shown that the RING ﬁnger domain
is not necessary for the repression activity of the Bmi-1 pro-
tein, while the helix-turn motif (HTHTHT) is required.
NSPc1 only has a RING ﬁnger domain but does not have
a helix-turn motif. Upon that, there is an interesting ques-
tion, which regions or sites are important for the repression
activity of NSPc1? We mapped the location of the repression
domain of NSPc1. It suggests that the RING ﬁnger of
NSPc1 is also not needed for repression but the C-terminal
is essential.
Phosphorylations of PcG proteins have been found impor-
tant to their functions. For example, Voncken et al. [21] have
reported that chromatin-association of the PcG protein Bmi-1
is cell cycle-regulated and correlates with its phosphorylation
Fig. 4. Relationship between the structure and the repression activity of NSPc1. (A) Brief illustration of the secondary structure and main
phosphorylation sites of NSPc1 protein. The analysis was mainly referred to PROSITE motif search and PHD predictions on website (http://
cubic.bioc.columbia.edu/predictprotein). (B) Repression activities of NSPc1 and its various derivatives. NSPc1 and its various derivatives were fused
to GAL4-DBD and transiently expressed in COS-7 cells with reporter genes. All constructs were schematically depicted in left (ﬁlled box,
representative of ring ﬁnger domain; asterisks show two putative phosphorylated sites that are important for repression; the numbers above the boxes
indicate the amino acid residue numbers of human NSPc1 and each mutant). The proteins used are denoted by appropriate abbreviations in the
middle. The repressor activities were assayed by luciferase activity as described in Section 2. Normalized relative luciferase activities of NSPc1 and its
derivatives were represented in right. The upmost dotted bar is pM-empty plasmid as the standard of whether a construct has a repression ability.
Results were obtained from four diﬀerent transfection experiments after normalization for the internal control of TK reporter activity and
experimental variations are indicated as shown.
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may be regulated by its phosphorylation status, with dephos-
phorylated Mel-18 forming homodimers, which dissociate
when phosphorylated by PKC. By mutagenesis of speciﬁc
phosphorylation sites, we found NSPc1-dependent transcrip-
tional repression mainly via the PKC phosphorylation site at
S183. Here, we need to point out that although NSPc1 lacks
the typical HTHTHT motif as Bmi-1, which is important for
the repression ability [17], NSPc1 has an a-helix within the
181–234 aa region as shown in Fig. 4A, and the 181–234 aa re-
gion of NSPc1 is probably equivalent to the HTHTHT motif
of Bmi1. It could be explained from our results that the muta-
tion of the PKC phosphorylation site at S183 may disrupt the
local secondary conformation of the a-helix and interfere with
subsequent protein-protein interactions that involved in tran-
scriptional repression processes, though the repression mecha-
nism of NSPc1 protein is not understood clearly. According to
the conception that the PcGs may recruit and interact withtranscription factors, including co-repressors and co-activa-
tors, we have found trans-activating eﬀect of some constructs
by using the GAL4 report system (Fig. 4B). We speculate that
some constructs may act as a dominant negative protein with
some cis or trans repression domains lost or uncovered by an
activating domain.
We also mutated the putative NLS sequence of NSPc1
(KRIR, amino acid from 109 to 112 aa), which was found
through alignment with Bmi-1 [17]. No diﬀerence was found
between the value of wild NSPc1 and mutation NLS-NSPc1
GAL4-DBD constructs (data not shown). We conclude that
KRIR may not be the only NLS of NSPc1, and that the KRIR
mutated NSPc1 can still be transported into the nucleus and
implement the transcriptional repression activity.
It is a pity that we cannot show the direct repressor eﬀect of
NSPc1 on a PRE-containing reporter plasmid, for the PRE
element is hitherto only well studied in Drosophila and there
is no vertebrate PcG protein, except YY1 [23], which has been
Fig. 5. Eﬀects of mutagenesis of NSPc1 on LUC-reporter gene transcription. (A) The scheme of mutagenesis. The tyrosine kinase phosphorylation
site at Y97F and the protein kinase C phosphorylation site at S183F of NSPc1 were mutated by PCR as described in Section 2. (B) Necessity of two
phosphorylation sites in C-terminal of NSPc1 for the mediation of transcription repression in vivo. COS-7 were transiently transfected with the wild
or mutated pM-NSPc1 expression plasmid (200 ng/well), together with pFR-Luc plasmid (200 ng/well), and pLR-TK plasmid (100 ng/well). Results
were obtained from three diﬀerent transfection experiments after normalization for the internal control of TK reporter activity and experimental
variations are indicated as shown. Asterisks indicate signiﬁcant changes in LUC activity (level of signiﬁcance equal to \P < 0.05 and \\P < 0.01).
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now dedicated ourselves to the research of whether NSPc1 is a
DNA binding factor.
In conclusion, similarities in nuclear localization and tran-
scriptional repression activity to previously deﬁned PcG pro-
teins suggest that NSPc1 is a member of the same subclass of
RING ﬁnger transcription factor family as Mel-18 and Bmi-1.
The mutagenesis analysis indicates that transcriptional repres-
sion activity ofNSPc1maybe related toPKC signaling pathway.
The PKC phosphorylation site at S183 could nevertheless be
functionally important for the transcriptional repression activ-
ity of NSPc1, although the biological relevance of how the
PKC activity regulates NSPc1 remains to be demonstrated.
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